Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

MYGN Stock Forecast, Price Targets, Chart, Dividends & Analysis

Myriad Genetics Inc. logo

Myriad Genetics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

26.43
 
USD
  
-0.53
  
(-1.97%)
Previous close: 26.96  Open: 26.77  Bid: 26.43  Ask: 27.4
52 week range    
13.82   
   29.30
Mkt Cap: 2,455 M  Avg Vol (90 Days): 743,226
Peers   
BIO / 
EXAS / 
BIOC / 
BMRN / 
ABT / 
Last updated: Friday 4th October 2024

Stock Rankings

42
MarketXLS Rank
60
Value
23
Technical
44
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABT

0.0196198 B35.7112.23

BGMD

BIO

9 B-16337.09

BIOC

00.4349

BMRN

13 B52.1568.16

EXAS

13 B66.41
Financials

MYGN Income Statement

Annual
Jun-14Jun-15Jun-16Jun-17Jun-18Jun-19Jun-20Dec-21Dec-22Dec-23
Amortization of intangibles-5 M-13 M-13 M-33 M-37 M685 M-7 M404 M380 M350 M
Basic EPS from continuing operations0.06-2.69-0.35-1.39-3.18
Basic EPS total2.331.121.790.31.920.06-2.69-0.35-1.39-3.18
Basic weighted shares outstanding76 M71 M70 M68 M69 M74 M74 M78 M81 M83 M
Cost of sales-96 M-133 M-133 M-145 M-149 M168 M186 M198 M202 M236 M
Depreciation-9 M-12 M-14 M-15 M-17 M73 M11 M12 M12 M19 M
Depreciation unreconciled-14 M-25 M-27 M-48 M-54 M
DepreciationAndAmortization-14 M-25 M-27 M-48 M-54 M73 M11 M12 M12 M19 M
Diluted EPS total2.251.081.710.31.850.06-2.69-0.35-1.39-3.18
Diluted normalized net income/share0.06-2.69-0.35-1.39-3.18
Diluted weighted shares outstanding78 M75 M73 M69 M72 M76 M74 M78 M81 M83 M
GainOnSaleOfBusiness1000000.0
GainOnSaleOfPPE1000000.0162 M-8 M
GainOnSaleOfSecurity-1 M
GeneralAndAdministrativeExpense-11 M-14 M-14 M-15 M-15 M556 M507 M538 M515 M573 M
Gross operating profit669 M576 M597 M599 M567 M683 M453 M505 M476 M517 M
ImpairmentOfCapitalAssets100 M2 M17 M
Income before tax278 M135 M169 M41 M120 M-223 M-57 M-141 M-262 M
Income restructuring and M&A-253 M-134 M-102 M-41 M
Income taxes102 M55 M44 M21 M-13 M-4 M-24 M-30 M-29 M1 M
Interest income5 M400000.0900000.01 M2 M3 M3 M700000.03 M3 M
InterestExpenseNonOperating300000.06 M3 M12 M11 M7 M3 M3 M
InterestExpenseOperating-6 M-3 M-12 M-9 M-4 M-1 M
MinorityInterests200000.0200000.0200000.0100000.0
MiscOtherSpecialCharges-2 M300000.02 M-3 M-400000.01 M16 M139 M600000.0-4 M
Net income from total operations176 M80 M125 M21 M133 M5 M-199 M-27 M-112 M-263 M
NetIncomeCommonStockholders176 M80 M125 M21 M133 M5 M-199 M-27 M-112 M-263 M
NetIncomeContinuousOperations176 M80 M125 M21 M133 M5 M-199 M-27 M-112 M-263 M
NetNonOperatingInterestIncomeExpense5 M400000.0600000.0-5 M-1 M-9 M-8 M-6 M-600000.0-400000.0
NonRecurringOperationExpense62 M113 M
Operating income274 M134 M167 M48 M61 M8 M-232 M-190 M-141 M-257 M
Operating income before depreciation (EBITDA)292 M160 M196 M90 M175 M73 M-140 M12 M-85 M-197 M
OperatingExpense395 M442 M430 M551 M506 M641 M585 M620 M600 M662 M
Other income net2 M-300000.0-1 M2 M-61 M-100000.0-16 M-139 M-600000.0-117 M
OtherGandA-11 M-14 M-14 M-15 M-15 M556 M507 M538 M515 M573 M
OtherImpairmentOfCapitalAssets18 M
OtherOperatingExpenses-2 M-1 M-600000.0-700000.0-600000.0-2 M-2 M-1 M-13 M-800000.0
RentAndLandingFees-11 M-14 M-14 M-15 M-15 M20 M
Research & development expense68 M76 M71 M74 M71 M86 M77 M82 M85 M89 M
ResearchExpense68 M76 M71 M74 M71 M86 M77 M82 M85 M89 M
RestructringAndMnAIncome-253 M-134 M-102 M-41 M
Revenue per share-5 M-13 M-13 M-33 M-37 M685 M-7 M404 M380 M350 M
SalariesAndWages-34 M-46 M-32 M-30 M-27 M34 M25 M36 M38 M41 M
Selling Gen & administrative expense327 M366 M359 M476 M435 M556 M507 M538 M515 M573 M
SellingAndMarketingExpense327 M366 M359 M476 M435 M
SellingExpense327 M366 M359 M476 M435 M
Special income/charges253 M134 M102 M41 M-100 M-64 M-17 M-113 M
Total Income available for interest expense (EBIT)278 M135 M169 M41 M120 M400000.0-212 M-50 M-137 M-259 M
Total common shares outstanding73 M69 M69 M68 M71 M74 M75 M80 M81 M90 M
Total net income176 M80 M125 M21 M133 M5 M-199 M-27 M-112 M-263 M
Total ordinary shares91 M91 M91 M91 M91 M91 M91 M91 M91 M91 M
Total revenues778 M723 M754 M770 M744 M851 M639 M691 M678 M753 M
TotalExpenses299 M309 M297 M406 M357 M810 M742 M805 M802 M898 M
TotalRevenue778 M723 M741 M770 M744 M851 M639 M691 M678 M753 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University